Cytek Biosciences (CTKB) Capital Expenditures (2020 - 2026)
Cytek Biosciences' (CTKB) quarterly Capital Expenditures came in at $2.2 million in Q1 2026, up 826.5% YoY from $234000.0 in Q1 2025, and up 173.39% on a QoQ basis from -$3.0 million in Q4 2025.
Cytek Biosciences (CTKB) Capital Expenditures (2020 - 2026) Analysis & Trends
Cytek Biosciences (CTKB) has 7 years of Capital Expenditures data on file, last reported at $2.2 million in Q1 2026.
- Quarterly Capital Expenditures rose 826.5% year-over-year to $2.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.1 million (up 1422.44% YoY) and the FY2025 annual result came in at $129000.0, down 27.12% from the prior year.
- Capital Expenditures climbed to $2.2 million in Q1 2026, from -$3.0 million in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $6.5 million in Q4 2022 to a low of -$3.1 million in Q4 2023.
- A 5-year average of $721294.1 and a median of $234000.0 in 2025 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2022 — Capital Expenditures soared 1199.42% — and 2025, when it tumbled 3887.18%.
- Tracing CTKB's Capital Expenditures over 5 years: stood at $6.5 million in 2022, then tumbled by 147.6% to -$3.1 million in 2023, then soared by 102.51% to $78000.0 in 2024, then plunged by 3887.18% to -$3.0 million in 2025, then soared by 173.39% to $2.2 million in 2026.
- The last three Capital Expenditures figures came in at $2.2 million (Q1 2026), -$3.0 million (Q4 2025), and $3.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 497.00 Mn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 202.00 Mn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 195.00 Mn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 66.90 Mn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 84.70 Mn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 100.00 Mn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | -74.39 Mn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 87.50 Mn |
| 10 | Cytek Biosciences | 611.56 Mn | 537.71 Mn | 28.34 Mn | 2.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.22 Mn |
| Jun 30, 2026 | 2.22 Mn |
| Mar 31, 2026 | 2.17 Mn |
| Mar 31, 2026 | 2.17 Mn |
| Dec 31, 2025 | -2.95 Mn |
| Dec 31, 2025 | -2.95 Mn |
| Sep 30, 2025 | 3.04 Mn |
| Sep 30, 2025 | 3.04 Mn |
| Jun 30, 2025 | -194,000.00 |
| Jun 30, 2025 | -194,000.00 |
| Mar 31, 2025 | 234,000.00 |
| Mar 31, 2025 | 234,000.00 |
| Dec 31, 2024 | 78,000.00 |
| Dec 31, 2024 | 78,000.00 |
| Sep 30, 2024 | -1.52 Mn |
| Sep 30, 2024 | -1.52 Mn |
| Jun 30, 2024 | 1.05 Mn |
| Jun 30, 2024 | 1.05 Mn |
| Mar 31, 2024 | 567,000.00 |
| Mar 31, 2024 | 567,000.00 |